OPTIMOX-aflibercept as First-line Therapy in Patients With Unresectable Metastatic Colorectal Cancer

NCT01802684 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Unresectable Metastatic Colorectal Cancer

Interventions

BIOLOGICAL: aflibercept

Sponsor

GERCOR - Multidisciplinary Oncology Cooperative Group

Collaborators

[object Object]